Repeated Autologous Bone Marrow Transfusion through Portal Vein for Treating Decompensated Liver Cirrhosis after Splenectomy
Objective. This study is aimed at examining the impact of repeated intraportal autologous bone marrow transfusion (ABMT) in patients with decompensated liver cirrhosis after splenectomy. Methods. A total of 25 patients with decompensated liver cirrhosis undergoing splenectomy were divided into ABMT...
Saved in:
Main Authors: | Weiwei Zhang, Mujian Teng, Baochi Liu, Qiling Liu, Xin Liu, Yanhui Si, Lei Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | Gastroenterology Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2018/4136082 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Extirpation of rectum for cancer in patient with decompensated liver cirrhosis and portal hypertension
by: P. V. Tsarkov, et al.
Published: (2011-09-01) -
Nomogram for Predicting Postoperative Portal Venous Systemic Thrombosis in Patients with Cirrhosis Undergoing Splenectomy and Esophagogastric Devascularization
by: Miao Chen, et al.
Published: (2022-01-01) -
Improving Survival in Decompensated Cirrhosis
by: Amar Nath Mukerji, et al.
Published: (2012-01-01) -
Management of Anticoagulation for Portal Vein Thrombosis in Individuals with Cirrhosis: A Systematic Review
by: Geneviève Huard, et al.
Published: (2012-01-01) -
CD300E+ macrophages facilitate liver regeneration after splenectomy in decompensated cirrhotic patients
by: Tao Yang, et al.
Published: (2025-01-01)